Sign in
Enrolling by invitationNo phase

Focused ultrasound for people with mild cognitive impairment

Tests focused ultrasound against a sham in people with mild cognitive impairment.

Key facts

Who runs it
Virginia Polytechnic Institute and State University
Where
Roanoke, United StatesSee the site
Trial code
Registry title
Mild Cognitive Impairment and Neuromodulation
Status
Enrolling by invitation
People taking part
40 people, planned
Starts
Dec 2026
Expected to end
Dec 2028
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Low intensity focused ultrasound
  • Sham (No Treatment)
Record updated
5 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 55 to 80 with mild cognitive impairment (mild memory and thinking problems). It tests low-intensity focused ultrasound on the brain against a sham (fake) treatment.

Age
55 Years to 80 Years
Sex
All
Disease stage
Mild cognitive impairment with a Montreal Cognitive Assessment (MoCA) score between 18-23 inclusive. People must be able to consent to their own medical care. The cause cannot be something other than Alzheimer's disease.
Earlier treatment
People cannot join if they take anti-amyloid antibodies. They cannot join if they had brain stimulation treatment (neuromodulation) within 6 months of the study.

Main reasons for not taking part

  • Fear of closed spaces (claustrophobia), or reasons they cannot have an MRI or CT scan, such as a pacemaker, metal implants or pregnancy
  • Memory problems from another cause, such as Lewy body disease, vascular dementia or alcohol or drug damage
  • History of another neurological disorder
  • Head injury with loss of consciousness for more than 10 min
  • Active alcohol or drug dependence

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Montreal Cognitive Assessment (MoCA) scores between 18-23 inclusive, and able to consent to their own medical care

Who cannot take part

  • MRI contraindications (pacemaker, aneurysm clips, neurostimulators, cochlear implants, metal in eyes, or other implants)
  • Taking anti-amyloid antibodies
  • Active alcohol or drug dependence
  • Non-AD etiology (eg. Lewy body disease, vascular dementia, alcohol/drug related damage)
  • History of other neurological disorder
  • Claustrophobia
  • CT contraindications (pregnancy)
  • Neuromod within 6 months of the study
  • Hx of head injury with LOC > 10 min

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 55 and 80 years old?

Where in United States

  • Fralin Biomedical Research Institute at VTCRoanoke, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

This is a parallel, sham-controlled design of low-intensity focused ultrasound in patients with mild cognitive impairment (MCI). The study will evaluate safety, tolerability, and effects on cognitive function.

The 2 groups in the trial

  • Real LIFUTreatment being tested

    Active Low Intensity Focused Ultrasound application

    Treatment: Low intensity focused ultrasound

  • Sham LIFUSham treatment, for comparison

    Blocked LIFU energy to the same brain region as the active group.

    Treatment: Sham (No Treatment)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
MCI - Mild Cognitive Impairment and Neuromodulation
Plain-language title
Focused ultrasound for people with mild cognitive impairmentGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT07691918, who can take part
Record updated
5 November 2026